Clinical Trials Browser

Phase 1 × Rectal Neoplasms × Celecoxib × Clear all

NCT00084721 2013-01-31

Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer

Phase 1 Completed

Gastrointestinal

Colonic Neoplasms, Diarrhea, Rectal Neoplasms, Colorectal Neoplasms